The differences observed in SSAT-1 activity were evident at higher stages of breast and lung cancer, but differences were not seen between healthy control and early stages of breast and lung cancer, which may be as a consequence of smaller sample size of patients with diagnosis of early-stage lung and breast cancer. The gene discussed is SAT1; the disease is breast cancer.